Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VIR BIOTECHNOLOGY, INC.

(VIR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 1 3793 4116 001--
Entreprise Value (EV)1 9962 6755 6385 3065 012
P/E ratio -2,18x-10,7x-17,4x-26,8x-44,6x
Yield -----
Capitalization / Revenue 170x44,7x18,1x11,1x8,96x
EV / Revenue 123x35,0x17,0x9,77x7,48x
EV / EBITDA -5,74x-9,17x-22,9x-156x-107x
Price to Book -----
Nbr of stocks (in thousands) 109 679127 389130 040--
Reference price (USD) 12,626,846,246,246,2
Last update 03/26/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020 2021 2022 2023
Net sales1 8,0976,4331543670
EBITDA1 -173-292-246-34,0-47,0
Operating profit (EBIT)1 -178-297-294-187-274
Operating Margin -2 200%-389%-88,9%-34,5%-41,0%
Pre-Tax Profit (EBT)1 -175-299-324-217-333
Net income1 -175-299-331-226-334
Net margin -2 159%-391%-100,0%-41,7%-49,8%
EPS2 -5,76-2,51-2,65-1,72-1,03
Dividend per Share2 -----
Last update 03/26/202002/25/202105/07/202105/07/202105/07/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt1 -----
Net Cash position1 383737364695989
Leverage (Debt / EBITDA) 2,21x2,53x1,48x20,4x21,0x
Free Cash Flow1 -139-197-236-28,270,0
ROE (Net Profit / Equities) --52,4%-65,7%-51,5%1,24%
Shareholders' equity1 -570504439-26 865
ROA (Net Profit / Asset) -49,6%-41,7%-48,8%-38,5%1,03%
Assets1 352715678589-32 363
Book Value Per Share -----
Cash Flow per Share2 --1,60-0,07-0,04-
Capex1 8,946,556,107,105,00
Capex / Sales 110%8,58%1,84%1,31%0,75%
Last update 03/26/202002/25/202106/03/202106/03/202106/03/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
6 001 338 523
Net sales (USD)
76 368 000
Number of employees
340
Sales / Employee (USD)
224 612
Free-Float
87,0%
Free-Float capitalization (USD)
5 218 314 796
Avg. Exchange 20 sessions (USD)
39 387 521
Average Daily Capital Traded
0,66%
EPS & Dividend